Irmandade Santa Casa de Misericordia de Porto Alegre

Porto Alegre, Rio Grande do Sul CEP 90020-090

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Cardiovascular Disease, Kidney Transplantation, Pancreatic Cancer, Prostatic Neoplasms

Studies at this site

• Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study — Enrolling by invitation
• Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed